CDEK
← All drugs Report issue

cipralisant

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

  • Histamine H3 receptorAGONIST

    HRH3 agonist

    GT-2331 exhibits differential pharmacology at the H3 receptor depending on which receptor mediated G-protein signalling pathway is examined (functional selectivity). May indicate presence of alternative ligand bound active state receptor conformations.

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1
Mol. weight
216.33 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole
  • cipralisant
  • cipralisant
  • cipralisant maleate
  • cipralisant maleate
  • gt 2331
  • gt-2331
  • gt-2331
  • gt-2331
  • perceptin
  • perceptin